Board of Directors
Eric Murphy, Ph.D.
Director & Co-Founder
Eric Murphy, Ph.D., co-founded Sidewinder Therapeutics and is a key contributor to the scientific and drug development strategy for the organization. He is also co-founder, Chief Executive Officer, and Chief Scientific Officer of Alterome Therapeutics. Dr. Murphy has over 20 years of drug discovery experience in small molecule oncology research across academia, clinical research organizations (CROs), biotech and large pharma. He was previously co-founder, Chief Scientific Officer, and Board / SAB member at both Kinnate Biopharma Inc. (KNTE) and Fount Therapeutics LLC. Prior to that, Dr. Murphy contributed to worldwide oncology research as the Global Head of Oncology R&D Strategy and External Innovations at Crown Bioscience prior to its acquisition by JSR Life Sciences. Eric and several Alterome team members have contributed to multiple approved oncology drugs and clinical stage oncology assets while at Novartis and Kinnate. Dr. Murphy completed his postdoctoral fellowship at The Scripps Research Institute with Dr. David Cheresh and holds a B.S. in biochemistry from the University of California at Davis. He holds a Ph.D. in biological sciences from the University of California at Irvine. He enjoys volunteering his time as a dedicated oncology patient empowerment advocate, mentor to early entrepreneurs and budding researchers, and San Diego community steward through non-profit organizations such as Life Science Cares San Diego.